Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms

The ability of monoclonal antibodies (mAbs) to target specific antigens with high precision has led to an increasing demand to generate them for therapeutic use in many disease areas. Historically, the discovery of therapeutic mAbs has relied upon the immunization of mammals and various in vitro dis...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:MAbs
Auteurs principaux: Abdiche, Yasmina Noubia, Harriman, Rian, Deng, Xiaodi, Yeung, Yik Andy, Miles, Adam, Morishige, Winse, Boustany, Leila, Zhu, Lei, Izquierdo, Shelley Mettler, Harriman, William
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2015
Sujets:
Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966639/
https://ncbi.nlm.nih.gov/pubmed/26652308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1118596
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires